Senseonics gets FDA approval for non-adjunctive indication for Eversense 90-day CGM system

Image: The US FDA’s Center for Devices and Radiological Health. Photo: courtesy of The U.S. Food and Drug Administration.



Related Article
Recommended Whitepaper

View More